Article Details

Acrux (ASX:ACR) wins FDA approval for generic topical solution

Retrieved on: 2021-06-22 06:56:15

Tags for this article:

Click the tags to see associated articles and topics

Acrux (ASX:ACR) wins FDA approval for generic topical solution. View article details on hiswai:

Excerpt

Acrux (ACR) gains FDA approval to market its generic version of the "Jublia" topical solution in the US; The Melbourne-based pharmaceutical ...

Article found on: themarketherald.com.au

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up